CoChat
Sign Up
Cited by 636Venous Thromboembolism Diagnosis and ManagementBlood Coagulation and Thrombosis MechanismsCerebral Venous Sinus Thrombosis

The DOI matches its Crossref record; 237 of the 240 references it cites were found in a registry or an index.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

Open access
Bates, Shannon M., Rajasekhar, Anita, Middeldorp, Saskia, McLintock, Claire, Rodger, Marc A., James, Andra H., Vazquez, Sara R., Greer, Ian A., Riva, John J., Bhatt, Meha, Schwab, Nicole, Barrett, Danielle, LaHaye, Andrea, Rochwerg, Bram·2018·Blood Advances
DOI 10.1182/bloodadvances.2018024802PMC PMC6258928
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Venous thromboembolism (VTE) complicates ∼1.2 of every 1000 deliveries. Despite these low absolute risks, pregnancy-associated VTE is a leading cause of maternal morbidity and mortality. OBJECTIVE: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians and others in decisions about the prevention and management of pregnancy-associated VTE. METHODS: ASH formed a multidisciplinary guideline panel balanced to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including updating or performing systematic evidence reviews. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess evidence and make recommendations. RESULTS: The panel agreed on 31 recommendations related to the treatment of VTE and superficial vein thrombosis, diagnosis of VTE, and thrombosis prophylaxis. CONCLUSIONS: There was a strong recommendation for low-molecular-weight heparin (LWMH) over unfractionated heparin for acute VTE. Most recommendations were conditional, including those for either twice-per-day or once-per-day LMWH dosing for the treatment of acute VTE and initial outpatient therapy over hospital admission with low-risk acute VTE, as well as against routine anti-factor Xa (FXa) monitoring to guide dosing with LMWH for VTE treatment. There was a strong recommendation (low certainty in evidence) for antepartum anticoagulant prophylaxis with a history of unprovoked or hormonally associated VTE and a conditional recommendation against antepartum anticoagulant prophylaxis with prior VTE associated with a resolved nonhormonal provoking risk factor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/bloodadvances.2018024802

Cites

237 of 237 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 240 references

3 of the 240 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Hassouna, 2010, Anticoagulation of pregnant women with mechanical heart valve prosthesis: a systematic review of the literature (2000-2009), J Coagul Disord, 2, 81

Cited by

Sorted by citations

Items 501–600 of 636

Related

See all

Metadata

Authors
Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., Vazquez, S. R., Greer, I. A., Riva, J. J., Bhatt, M., Schwab, N., Barrett, D., LaHaye, A., & Rochwerg, B.
Affiliations
  • Thrombosis and Atherosclerosis Research Institute (CA)
  • University of Florida Health (US)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Auckland City Hospital (NZ)
  • University of Ottawa (CA)
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, NC;
  • University of Utah (US)
  • Queen's University Belfast (GB)
  • McMaster University (CA)
  • University of Toronto (CA)
  • Wake Forest University (US)
  • Alexandria, VA; and
ORCID
Venue
Blood Advances
Publisher
American Society of Hematology
Published
2018-11-27
Volume
2
Issue
22
Pages
3317-3359
ISSN
  • 2473-9529 (ISSN-L)
  • 2473-9537
DOI
10.1182/bloodadvances.2018024802
PMC
PMC6258928
OpenAlex
W2903022860
Cited by
625
References
240
Citations by year
2026: 94 · 2025: 89 · 2024: 90 · 2023: 79 · 2022: 81 · 2021: 86 · 2020: 70 · 2019: 33 · 2018: 2
FWCI
45.21
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Blood Advances (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Cerebral Venous Sinus Thrombosis
Keywords
venous thromboembolism, pregnancy, thromboprophylaxis, low molecular weight heparin, unfractionated heparin, anti-factor Xa monitoring, superficial thrombophlebitis, VTE diagnosis, maternal morbidity, anticoagulant dosing
MeSH terms
Administration, Oral, Anticoagulants, Breast Feeding, Female, Fibrinolytic Agents, Heparin, Low-Molecular-Weight, Humans, Infant, Infant, Newborn, Pregnancy, Evidence-Based Medicine, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review